Objectives: The aim of this study of this study was to evaluate preoperative radiology and histopathology findings in cervical cancer lymphadenopathy detection, allowing targeted frozen section examination (FSE). Design: A retrospective analysis was conducted of 203 early-stage cervical cancer patients between 2010 and 2019 in a tertiary centre. Participants/Materials, Setting, and Methods: All patients had histologically confirmed cervical cancer and underwent magnetic resonance imaging (MRI) prior to intraoperative FSE. The primary objectives of the study were to determine the diagnostic accuracy of intraoperative FSE in the identification of lymph node metastases (LNM) in early-stage cervical cancer by correlation with final results obtained using standard histopathology techniques and to examine different preoperative, intraoperative, demographic, radiological, and histopathological factors that could identify those at greatest risk of nodal disease and hence predict those most likely to benefit from FSE, enabling more selective and targeted use. Results: Nineteen patients were found to have LNM (9.36%) at FSE. Patients were at increased risk of LNM by 6-fold with positive LVSI, 3-fold with MRI lymphadenopathy, and 3.5-fold with MRI-visible disease. The presence of lymphadenopathy on MRI and positive LVSI in combination increased the risk of LNM by 19-fold. Limitations: We acknowledge that FSE is expensive and time intensive, exposing patients to increased surgery duration and associated risk. We also recognize that it may not be feasible for all patients. Finally, the analysis is limited by retrospective nature of the study. Conclusions: By application of the preoperative risk stratification algorithm, we may suggest that FSE can be a useful tool in high-risk patients.

1.
Arbyn
M
,
Weiderpass
E
,
Bruni
L
,
de Sanjosé
S
,
Saraiya
M
,
Ferlay
J
, et al
.
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
.
Lancet Glob Health
.
2020
;
8
(
2
):
e191
203
.
2.
Perkins
RB
,
Wentzensen
N
,
Guido
RS
,
Schiffman
M
.
Cervical cancer screening: a review
.
JAMA
.
2023
;
330
(
6
):
547
58
.
3.
Brakebill
A
,
Morgan
A
,
Lieberman
RW
.
Primary HPV screening vs cotesting for cervical cancer
.
JAMA
.
2023
;
330
(
21
):
2121
.
4.
Reed
N
,
Balega
J
,
Barwick
T
,
Buckley
L
,
Burton
K
,
Eminowicz
G
, et al
.
British Gynaecological Cancer Society (BGCS) cervical cancer guidelines: recommendations for practice
.
Eur J Obstet Gynecol Reprod Biol
.
2021
;
256
:
433
65
.
5.
Bouvard
V
,
Wentzensen
N
,
Mackie
A
,
Berkhof
J
,
Brotherton
J
,
Giorgi-Rossi
P
, et al
.
The IARC perspective on cervical cancer screening
.
N Engl J Med
.
2021
;
385
(
20
):
1908
18
.
6.
D’Oria
O
,
Corrado
G
,
Laganà
AS
,
Chiantera
V
,
Vizza
E
,
Giannini
A
.
New advances in cervical cancer: from bench to bedside
.
Int J Environ Res Public Health
.
2022
;
19
(
12
):
7094
.
7.
Castanon
A
,
Landy
R
,
Pesola
F
,
Windridge
P
,
Sasieni
P
.
Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study
.
Lancet Public Health
.
2018
;
3
(
1
):
e34
43
.
8.
Marth
C
,
Landoni
F
,
Mahner
S
,
McCormack
M
,
Gonzalez-Martin
A
,
Colombo
N
, et al
.
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
.
Ann Oncol
.
2017
;
28
(
Suppl l_4
):
iv72
83
.
9.
Benedetti-Panici
P
,
Maneschi
F
,
Scambia
G
,
Greggi
S
,
Cutillo
G
,
D’Andrea
G
, et al
.
Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy
.
Gynecol Oncol
.
1996
;
62
(
1
):
19
24
.
10.
Benedetti Panici
P
,
Basile
S
,
Angioli
R
.
Pelvic and aortic lymphadenectomy in cervical cancer: the standardization of surgical procedure and its clinical impact
.
Gynecol Oncol
.
2009
;
113
(
2
):
284
90
.
11.
Devine
C
,
Viswanathan
C
,
Faria
S
,
Marcal
L
,
Sagebiel
TL
.
Imaging and staging of cervical cancer
.
Semin Ultrasound CT MR
.
2019
;
40
(
4
):
280
6
.
12.
Bhatla
N
,
Berek
JS
,
Cuello Fredes
M
,
Denny
LA
,
Grenman
S
,
Karunaratne
K
, et al
.
Revised FIGO staging for carcinoma of the cervix uteri
.
Int J Gynaecol Obstet
.
2019
;
145
(
1
):
129
35
.
13.
Du
R
,
Li
L
,
Ma
S
,
Tan
X
,
Zhong
S
,
Wu
M
.
Lymph nodes metastasis in cervical cancer: incidences, risk factors, consequences and imaging evaluations
.
Asia Pac J Clin Oncol
.
2018
;
14
(
5
):
e380
5
.
14.
Wang
Y
,
Yao
T
,
Yu
J
,
Li
J
,
Chen
Q
,
Lin
Z
.
Can pelvic lymphadenectomy be omitted in patients with stage IA2, IB1, and IIA1 squamous cell cervical cancer
.
Springerplus
.
2016
;
5
(
1
):
1262
.
15.
Gubbala
K
,
Laios
A
,
Madhuri
TK
,
Pathiraja
P
,
Haldar
K
,
Kehoe
S
.
Results from survey to assess current trends in surgical practice in the management of women with early stage cervical cancer within the BGCS community with an emphasis on routine frozen section examination
.
Int J Surg Oncol
.
2017
;
2017
:
2962450
.
16.
Garg
G
,
Shah
JP
,
Toy
EP
,
Field
JB
,
Bryant
CS
,
Liu
JR
, et al
.
Intra-operative detection of nodal metastasis in early stage cervical cancer: a survey of the practice patterns of SGO members
.
Gynecol Oncol
.
2011
;
121
(
1
):
143
7
.
17.
Cibula
D
,
Pötter
R
,
Planchamp
F
,
Avall-Lundqvist
E
,
Fischerova
D
,
Haie Meder
C
, et al
.
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer
.
Radiother Oncol
.
2018
;
127
(
3
):
404
16
.
18.
Ramirez
PT
,
Frumovitz
M
,
Pareja
R
,
Lopez
A
,
Vieira
M
,
Ribeiro
R
, et al
.
Minimally invasive versus abdominal radical hysterectomy for cervical cancer
.
N Engl J Med
.
2018
;
379
(
20
):
1895
904
.
19.
Gitas
G
,
Pados
G
,
Laganà
AS
,
Guenther
V
,
Ackermann
J
,
Alkatout
I
.
Role of laparoscopic hysterectomy in cervical and endometrial cancer: a narrative review
.
Minim Invasive Ther Allied Technol
.
2023
;
32
(
1
):
1
11
.
20.
Di Donna
MC
,
Giallombardo
V
,
Lo Balbo
G
,
Cucinella
G
,
Sozzi
G
,
Capozzi
VA
, et al
.
Conventional laparoscopy versus robotic-assisted aortic lymph-nodal staging for locally advanced cervical cancer: a systematic review and meta-analysis
.
J Clin Med
.
2022
;
11
(
12
):
3332
.
21.
Saleh
M
,
Virarkar
M
,
Javadi
S
,
Elsherif
SB
,
de Castro Faria
S
,
Bhosale
P
.
Cervical cancer: 2018 revised International federation of gynecology and obstetrics staging system and the role of imaging
.
AJR Am J Roentgenol
.
2020
;
214
(
5
):
1182
95
.
22.
Hong
K-S
,
Ju
W
,
Choi
HJ
,
Kim
JK
,
Kim
M
,
Cho
K-S
.
Differential diagnostic performance of magnetic resonance imaging in the detection of lymph node metastases according to the tumor size in early-stage cervical cancer patients
.
Int J Gynecol Cancer
.
2010
;
20
(
5
):
841
6
.
23.
Allahqoli
L
,
Hakimi
S
,
Laganà
AS
,
Momenimovahed
Z
,
Mazidimoradi
A
,
Rahmani
A
, et al
.
18F-FDG PET/MRI and 18F-FDG PET/CT for the management of gynecological malignancies: a comprehensive review of the literature
.
J Imaging
.
2023
;
9
(
10
):
223
.
24.
Allahqoli
L
,
Laganà
AS
,
Mazidimoradi
A
,
Salehiniya
H
,
Günther
V
,
Chiantera
V
, et al
.
Diagnosis of cervical cancer and pre-cancerous lesions by artificial intelligence: a systematic review
.
Diagnostics
.
2022
;
12
(
11
):
2771
.
25.
Lécuru
F
,
Mathevet
P
,
Querleu
D
,
Leblanc
E
,
Morice
P
,
Daraï
E
, et al
.
Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study
.
J Clin Oncol
.
2011
;
29
(
13
):
1686
91
.
26.
Selman
TJ
,
Mann
C
,
Zamora
J
,
Appleyard
T-L
,
Khan
K
.
Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis
.
CMAJ
.
2008
;
178
(
7
):
855
62
.
27.
Cibula
D
,
Kocian
R
,
Plaikner
A
,
Jarkovsky
J
,
Klat
J
,
Zapardiel
I
, et al
.
Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: the SENTIX trial
.
Eur J Cancer
.
2020
;
137
:
69
80
.
28.
Frumovitz
M
,
Plante
M
,
Lee
PS
,
Sandadi
S
,
Lilja
JF
,
Escobar
PF
, et al
.
Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial
.
Lancet Oncol
.
2018
;
19
(
10
):
1394
403
.
29.
Bats
A-S
,
Mathevet
P
,
Buenerd
A
,
Orliaguet
I
,
Mery
E
,
Zerdoud
S
, et al
.
The sentinel node technique detects unexpected drainage pathways and allows nodal ultrastaging in early cervical cancer: insights from the multicenter prospective SENTICOL study
.
Ann Surg Oncol
.
2013
;
20
(
2
):
413
22
.
30.
Balaya
V
,
Guani
B
,
Benoit
L
,
Magaud
L
,
Bonsang-Kitzis
H
,
Ngô
C
, et al
.
Diagnostic value of frozen section examination of sentinel lymph nodes in early-stage cervical cancer at the time of ultrastaging
.
Gynecol Oncol
.
2020
;
158
(
3
):
576
83
.
31.
Rychlik
A
,
Angeles
MA
,
Migliorelli
F
,
Croce
S
,
Mery
E
,
Martinez
A
, et al
.
Frozen section examination of sentinel lymph nodes can be used as a decisional tool in the surgical management of early cervical cancer
.
Int J Gynecol Cancer
.
2020
;
30
(
3
):
358
63
.
32.
Dostalek
L
,
Slama
J
,
Fisherova
D
,
Kocian
R
,
Germanova
A
,
Fruhauf
F
, et al
.
Impact of sentinel lymph node frozen section evaluation to avoid combined treatment in early-stage cervical cancer
.
Int J Gynecol Cancer
.
2020
;
30
(
6
):
744
8
.
33.
Papadia
A
,
Morosi
C
,
Wang
J
,
Gasparri
ML
,
Rau
T
,
Ghezzi
F
, et al
.
SLN mapping in early-stage cervical cancer as a minimal-invasive triaging tool for multimodal treatment
.
Eur J Surg Oncol
.
2019
;
45
(
4
):
679
83
.
34.
Martínez
A
,
Mery
E
,
Filleron
T
,
Boileau
L
,
Ferron
G
,
Querleu
D
.
Accuracy of intraoperative pathological examination of SLN in cervical cancer
.
Gynecol Oncol
.
2013
;
130
(
3
):
525
9
.
35.
Cibula
D
,
McCluggage
WG
.
Sentinel lymph node (SLN) concept in cervical cancer: current limitations and unanswered questions
.
Gynecol Oncol
.
2019
;
152
(
1
):
202
7
.
36.
Mathevet
P
,
Lécuru
F
,
Uzan
C
,
Boutitie
F
,
Magaud
L
,
Guyon
F
, et al
.
Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: results of a multicentre randomised trial (SENTICOL-2)
.
Eur J Cancer
.
2021
;
148
:
307
15
.
37.
Salvo
G
,
Ramirez
PT
,
Levenback
CF
,
Munsell
MF
,
Euscher
ED
,
Soliman
PT
, et al
.
Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer
.
Gynecol Oncol
.
2017
;
145
(
1
):
96
101
.
38.
Guani
B
,
Balaya
V
,
Magaud
L
,
Lecuru
F
,
Mathevet
P
.
The clinical impact of low-volume lymph nodal metastases in early-stage cervical cancer: the senticol 1 and senticol 2 trials
.
Cancers
.
2020
;
12
(
5
):
1061
.
39.
Favre
G
,
Guani
B
,
Balaya
V
,
Magaud
L
,
Lecuru
F
,
Mathevet
P
.
Sentinel lymph-node biopsy in early-stage cervical cancer: the 4-year follow-up results of the senticol 2 trial
.
Front Oncol
.
2020
;
10
:
621518
.
40.
Gubbala
PK
,
Laios
A
,
Wang
Z
,
Dhar
S
,
Pathiraja
PJ
,
Haldar
K
, et al
.
Routine intraoperative frozen section examination to minimize bimodal treatment in early-stage cervical cancer
.
Int J Gynecol Cancer
.
2016
;
26
(
6
):
1148
53
.
41.
Cibula
D
,
Dostalek
L
,
Hillemanns
P
,
Scambia
G
,
Jarkovsky
J
,
Persson
J
, et al
.
Completion of radical hysterectomy does not improve survival of patients with cervical cancer and intraoperatively detected lymph node involvement: ABRAX International retrospective cohort study
.
Eur J Cancer
.
2021
;
143
:
88
100
.
42.
Liu
P
,
Liang
C
,
Lu
A
,
Chen
X
,
Liang
W
,
Li
D
, et al
.
Risk factors and long-term impact of urologic complications during radical hysterectomy for cervical cancer in China, 2004-2016
.
Gynecol Oncol
.
2020
;
158
(
2
):
294
302
.
43.
Fletcher
D
,
Edwards
D
,
Tolchard
S
,
Baker
R
,
Berstock
J
.
Improving theatre turnaround time
.
BMJ Qual Improv Rep
.
2017
;
6
(
1
):
u219831.w8131
.
44.
Nanthamongkolkul
K
,
Hanprasertpong
J
.
Predictive factors of pelvic lymph node metastasis in early-stage cervical cancer
.
Oncol Res Treat
.
2018
;
41
(
4
):
194
8
.
45.
Lucia
F
,
Bourbonne
V
,
Pleyers
C
,
Dupré
P-F
,
Miranda
O
,
Visvikis
D
, et al
.
Multicentric development and evaluation of 18F-FDG PET/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical cancer
.
Eur J Nucl Med Mol Imaging
.
2023
;
50
(
8
):
2514
28
.
46.
Mitchell
DG
,
Snyder
B
,
Coakley
F
,
Reinhold
C
,
Thomas
G
,
Amendola
MA
, et al
.
Early invasive cervical cancer: MRI and CT predictors of lymphatic metastases in the ACRIN 6651/GOG 183 intergroup study
.
Gynecol Oncol
.
2009
;
112
(
1
):
95
103
.
47.
Roh
HJ
,
Kim
KB
,
Lee
JH
,
Kim
HJ
,
Kwon
Y-S
,
Lee
SH
.
Early cervical cancer: predictive relevance of preoperative 3-tesla multiparametric magnetic resonance imaging
.
Int J Surg Oncol
.
2018
;
2018
:
9120753
.
48.
Kim
SH
,
Lee
HJ
,
Kim
YW
.
Correlation between tumor size and surveillance of lymph node metastasis for IB and IIA cervical cancer by magnetic resonance images
.
Eur J Radiol
.
2012
;
81
(
8
):
1945
50
.
49.
Park
S-H
,
Hahm
MH
,
Bae
BK
,
Chong
GO
,
Jeong
SY
,
Na
S
, et al
.
Magnetic resonance imaging features of tumor and lymph node to predict clinical outcome in node-positive cervical cancer: a retrospective analysis
.
Radiat Oncol
.
2020
;
15
(
1
):
86
.
50.
Hou
L
,
Zhou
W
,
Ren
J
,
Du
X
,
Xin
L
,
Zhao
X
, et al
.
Radiomics analysis of multiparametric MRI for the preoperative prediction of lymph node metastasis in cervical cancer
.
Front Oncol
.
2020
;
10
:
1393
.
You do not currently have access to this content.